My last question is for Merck.
With respect to the $300 million for the vaccine for young women, is the $100 million a leverage issue that we try to get other provinces on board with? Who decides which vaccine--it might not be a Merck vaccine, because other people do produce vaccines in the world--gets funded and which one doesn't?